Aurinia Pharmaceuticals Inc. ( AUPH) - Key Metrics

AUPH Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $0.64 $0.29 $0.40 $0.40
2026Q1 $0.59 $0.26 $0.25 $0.25
2025Q4 $0.57 $1.57 $0.33 $0.33
2025Q3 $0.54 $0.23 $0.32 $0.32
2025Q2 $0.50 $0.15 $0.32 $0.32

AUPH Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 14.63
2026Q1 0% 14.25
2025Q4 0% 2.52
2025Q3 0% 11.51
2025Q2 0% 13.23

AUPH Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 2.36% 0%
2026Q1 1.66% 0%
2025Q4 2.08% 0%
2025Q3 2.93% 0%
2025Q2 3.75% 0%

AUPH

Price: $15.47

52 week price:
10.34
19.25

Earnings Per Share: 2.28 USD

P/E Ratio: 6.74

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 2.2 million

Ebitda: -13.4 million

Market Capitalization: 2.0 billion

Links: